Centre Antoine Lacassagne
Clinical trials sponsored by Centre Antoine Lacassagne, explained in plain language.
-
One-and-done radiation for prostate cancer shows promise in early trial
Disease control CompletedThis study tested a single, high-dose radiation treatment for men with low-risk prostate cancer. The goal was to see how well patients tolerated the procedure and what side effects occurred within the first 6 months. 35 patients received the treatment, and researchers monitored u…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Disease control
Last updated May 15, 2026 11:56 UTC
-
New combo therapy for breast cancer shows promise in early trial
Disease control CompletedThis early-phase study tested a new approach for women with breast cancer who cannot have breast-conserving surgery. It combined a short course of high-dose radiation (CyberKnife) with standard chemotherapy drugs. The main goal was to find the safest radiation dose and check for …
Phase: PHASE1 • Sponsor: Centre Antoine Lacassagne • Aim: Disease control
Last updated May 14, 2026 12:04 UTC
-
One-and-Done radiation boost shows promise for breast cancer patients
Disease control CompletedThis study tested a new way to give an extra dose of radiation (a boost) to the tumor site after standard breast radiation. Instead of multiple sessions, the CyberKnife machine delivered a single high dose very precisely, aiming to reduce skin damage and improve cosmetic results.…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Disease control
Last updated May 14, 2026 12:03 UTC
-
Precision radiation boosts lung cancer fight after chemo
Disease control CompletedThis study tested whether adding a precise, high-dose radiation treatment (CyberKnife) after standard chemo and radiation could improve outcomes for people with stage III non-small cell lung cancer. It involved 35 patients whose tumors had not spread but could not be removed by s…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Disease control
Last updated May 14, 2026 12:02 UTC
-
Triple therapy shows promise for aggressive head and neck cancers
Disease control CompletedThis study tested a combination of chemotherapy, radiation, and a targeted drug called cetuximab in 53 patients with head and neck cancer who had a high risk of the cancer coming back after surgery. The goal was to see if this triple therapy could keep the cancer from returning f…
Phase: PHASE2 • Sponsor: Centre Antoine Lacassagne • Aim: Disease control
Last updated May 14, 2026 12:01 UTC
-
Can special nutrition cut infection risk after cancer surgery?
Disease control CompletedThis study tested three different nutrition plans given through a feeding tube after surgery for head and neck cancer. The goal was to see which plan best prevents infections. The trial included 311 adults scheduled for tumor removal. Results help guide post-surgery care to reduc…
Phase: PHASE3 • Sponsor: Centre Antoine Lacassagne • Aim: Disease control
Last updated May 12, 2026 13:40 UTC
-
New drug cocktail shows promise for tough pancreatic cancer
Disease control CompletedThis early-phase study tested a combination of three drugs (gemcitabine, capecitabine, and erlotinib) in 30 people with advanced pancreatic cancer that had already been treated. The main goal was to find the safest dose and understand side effects. This is not a cure, but a way t…
Phase: PHASE1 • Sponsor: Centre Antoine Lacassagne • Aim: Disease control
Last updated May 11, 2026 20:47 UTC
-
New combo therapy shows promise for lymphoma in seniors
Disease control CompletedThis study tested a combination of chemotherapy (CHOP), a targeted antibody (rituximab), and a radioactive antibody (Y90 ibritumomab tiuxetan) in 30 adults aged 65-80 with newly diagnosed large B-cell lymphoma. The goal was to see if this approach could improve event-free surviva…
Phase: PHASE2 • Sponsor: Centre Antoine Lacassagne • Aim: Disease control
Last updated May 07, 2026 18:39 UTC
-
Can MRI better measure early breast cancer?
Diagnosis CompletedThis study looked at how well MRI scans can measure the size of ductal carcinoma in situ (DCIS), a very early form of breast cancer. Forty women with DCIS had an MRI before surgery, and the MRI results were compared to the actual tumor size found during surgery. The goal was to s…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Diagnosis
Last updated May 17, 2026 00:42 UTC
-
New PET scan trick may spot fake tumor growth in immunotherapy patients
Diagnosis CompletedThis study looked at 100 people with advanced lung cancer or melanoma who were getting immunotherapy. Researchers used a special PET scan to see if they could tell the difference between real tumor growth and inflammation that looks like growth. The goal was to improve how doctor…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Diagnosis
Last updated May 04, 2026 16:19 UTC
-
New brain scan may end diagnostic delays for tumor patients
Diagnosis CompletedThis study looked at whether a special PET scan using 18F-FDOPA can help doctors decide on the best treatment for people with brain tumors (gliomas or metastases) when MRI results are unclear. 85 patients were enrolled. The goal was to see if the PET scan increased doctors' confi…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Diagnosis
Last updated May 01, 2026 16:00 UTC
-
Phone Check-Ins ease chemo side effects, study finds
Symptom relief CompletedThis study looked at whether two phone calls during the first three rounds of chemotherapy could help patients with breast or colon cancer feel less anxious and manage side effects better. About 274 patients took part, and researchers measured their mood, quality of life, and sid…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Symptom relief
Last updated May 13, 2026 16:02 UTC
-
Seed vs wire: which tumor marker leads to cleaner breast cancer surgery?
Symptom relief CompletedThis study tested two ways to mark small, non-palpable breast tumors before surgery: a tiny radioactive seed (iodine-125) versus a standard metal wire. 350 women with early-stage breast cancer took part. The goal was to see if the seed method helps surgeons remove the tumor compl…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Symptom relief
Last updated May 11, 2026 20:51 UTC
-
Elderly cancer care gets a closer look: study tracks quality of life
Knowledge-focused CompletedThis study followed 76 adults over 70 with solid tumors to see how their quality of life changed during chemotherapy. Researchers used simple questionnaires about daily activities and mental health to understand each person's needs. The goal was to learn how to better tailor canc…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated May 17, 2026 00:43 UTC
-
Cancer Patients' taste changes may derail healthy eating, study finds
Knowledge-focused CompletedThis study looked at how cancer treatment changes patients' sense of taste and smell, and how that affects their ability to follow a Mediterranean diet. Researchers followed 116 cancer patients before and after 9 weeks of treatment, comparing those with sensory changes to those w…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated May 17, 2026 00:41 UTC
-
Gene test may predict dangerous chemo reactions
Knowledge-focused CompletedThis study looked at whether a genetic condition called DPD deficiency can predict severe side effects from the chemotherapy drug capecitabine in women with metastatic breast cancer. Researchers analyzed blood samples from 303 participants to see if those with the deficiency had …
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated May 17, 2026 00:40 UTC
-
Scientists hunt for hidden metabolic fingerprints in breast tumors
Knowledge-focused CompletedThis study examined 52 breast cancer tumor samples and some blood samples to find unique metabolic patterns. The goal was to better understand different types of breast cancer and discover possible markers for diagnosis or treatment targets. Participants were women who had surger…
Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated May 17, 2026 00:31 UTC
-
Brain scan shakes up tumor treatment plans in 4 out of 10 cases
Knowledge-focused CompletedThis study tested whether a costly PET scan called 18F-FDOPA helps doctors make better treatment choices for people with high-grade gliomas, a type of aggressive brain tumor. About 110 patients whose cases were discussed by a team of brain-tumor specialists took part. The main go…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated May 17, 2026 00:28 UTC
-
Cancer patients face double threat: clots and bleeding risks
Knowledge-focused CompletedThis study looked at how often cancer patients develop dangerous blood clots, especially those who also have bleeding problems or take blood thinners. Researchers followed 700 hospitalized cancer patients to track clot rates and understand risk factors. The goal was to gather inf…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated May 17, 2026 00:28 UTC
-
New radiation method during breast surgery shows promise in small study
Knowledge-focused CompletedThis study tested a new way to give radiation therapy during breast cancer surgery (called intraoperative radiotherapy) in 28 women aged 60 or older with early-stage breast cancer. The goal was to see if the technique could deliver the right dose of radiation to the tumor area sa…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated May 15, 2026 11:54 UTC
-
Study reveals what breast cancer patients really think about exercise
Knowledge-focused CompletedThis study looked at 422 breast cancer patients to understand how their knowledge about exercise, their current activity level, and their fatigue affect their beliefs about physical activity and their desire to be active. The goal was to learn what influences their motivation, no…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated May 14, 2026 12:06 UTC
-
New study tracks swallowing troubles after head and neck cancer therapy
Knowledge-focused CompletedThis study followed 240 people with head and neck cancer to see how their first treatment affected their ability to swallow. Researchers used a special questionnaire and doctor exams to track swallowing problems from diagnosis up to 18 months after treatment. The goal was to unde…
Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC
-
Hidden COVID-19 cases in cancer patients revealed by rapid testing
Knowledge-focused CompletedThis study aimed to find out how many cancer patients had COVID-19, including those without symptoms. Researchers used a rapid blood test to check for antibodies in 214 patients receiving cancer treatment. The goal was to better understand infection risks and help hospitals keep …
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated May 14, 2026 12:02 UTC
-
Radiotherapy chat eases cancer patient worries, study finds
Knowledge-focused CompletedThis study looked at whether having an extra talk with a radiotherapy technician helps cancer patients get better information about their treatment. Over 300 adults with various cancers took part. The goal was to see if this extra chat reduces anxiety and helps patients feel more…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated May 11, 2026 20:41 UTC
-
Iron deficiency in cancer patients: a hidden problem?
Knowledge-focused CompletedThis study looked at how common iron deficiency is in 480 cancer patients about to start chemotherapy. The goal was to find out how many might benefit from iron injections. No new treatments were tested; instead, researchers measured iron levels using blood tests to better unders…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated May 08, 2026 12:02 UTC
-
New oxygen method may be safer for head and neck cancer procedures
Knowledge-focused CompletedThis study looked at 160 people with head and neck cancer who needed a diagnostic exam called panendoscopy under general anesthesia. Researchers compared standard oxygen therapy with a high-flow system called THRIVE (Optiflow) to see which one better prevents drops in oxygen leve…
Phase: NA • Sponsor: Centre Antoine Lacassagne • Aim: Knowledge-focused
Last updated May 08, 2026 12:00 UTC